A Study to Test the Pharmacokinetics, Efficacy, and Safety of Brivaracetam in Newborns With Repeated Electroencephalographic Seizures

Stopped Terminated (The study stopped prematurely due to enrolment challenges, the termination was not linked to any safety issues.)

Conditions

• Electroencephalographic Neonatal Seizures

Interventions

• DRUG: Brivaracetam (BRV) intravenous (iv)
• DRUG: Brivaracetam (BRV) oral

Sponsor

UCB Biopharma SRL